The U.S. scar treatment market was valued at $4,757.8 million in 2014, and it is expected to grow with a CAGR of 10.2% during the period 2015 – 2020. The U.S. scar treatment market is growing, owing to the increasing prevalence of skin problems leading to scar formation, increasing appearance consciousness among consumers and increasing expenditure on personal care. In addition, the availability of technologically advanced scar treatment products and therapies is encouraging the growth of the U.S. scar treatment market.
Among the two segments of scar treatment market, the product segment is expected to witness the faster growth during the forecast period. Among the various scar treatment therapies, the Dermabrasion segment accounted for the largest share in the U.S. market in 2014, and it is expected to witness a CAGR of 9.0% during the 2015 – 2020.
The increasing prevalence of skin problems, due to excessive exposure to pollution and UV radiation, results in sunburns, reduced skin elasticity, and other skin diseases. These conditions, without proper treatment on time, can lead to the formation of scars. Various other skin problems, such as acne, burns, post-surgical marks and stretch marks, due to pregnancy or changes in body weight also lead to scar formation, which is boosting the demand of scar treatment products and therapies.
Furthermore, the technological advancements in scar treatment products and therapies help in the removal of scars easily. The availability of various products, such as creams, oils, gels, and sprays over the counter for treating scars leads to the growth of the U.S. scar treatment market.
However, the high cost associated with the treatment of scars is a key restraint in the growth of the scar treatment market in the U.S. The scar treatment products, such as gels, creams, sprays, and oils are costly. Scar removal therapies are also capital intensive and require skilled practitioners, which further adds to the overall cost of treatment. In addition, the side effects of scar treatment products and therapies further restrain the growth of the market.
The key companies operating in the U.S. scar treatment market include Pacific World Corporation, MerzPharma, Johnson & Johnson Services Inc., Valeant Pharmaceuticals International Inc., Oculus Innovative Sciences Inc. Enaltus LLC, Revitol Corporation Inc., Scarguard Labs LLC, Quantum Health and CCA Industries Inc.
News Courtesy: P&S Market Research